These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3117104

  • 1. A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin-binding and tissue plasminogen activator catalytic domains.
    Robbins KC, Boreisha IG.
    Biochemistry; 1987 Jul 28; 26(15):4661-7. PubMed ID: 3117104
    [Abstract] [Full Text] [Related]

  • 2. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC, Tanaka Y.
    Biochemistry; 1986 Jun 17; 25(12):3603-11. PubMed ID: 2941075
    [Abstract] [Full Text] [Related]

  • 3. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH, Nieuwenbroek NM, Verheijen JH.
    Protein Eng; 1995 Dec 17; 8(12):1295-1302. PubMed ID: 8869642
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D, Lijnen HR, Piérard L, de Foresta F, Demarsin E, Jacobs P, De Wilde M, Bollen A, Collen D.
    J Biol Chem; 1987 Aug 25; 262(24):11779-84. PubMed ID: 3114253
    [Abstract] [Full Text] [Related]

  • 5. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
    Lee PP, Wohl RC, Boreisha IG, Robbins KC.
    Biochemistry; 1988 Sep 20; 27(19):7506-13. PubMed ID: 2974723
    [Abstract] [Full Text] [Related]

  • 6. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes.
    Lee SG, Kalyan N, Wilhelm J, Hum WT, Rappaport R, Cheng SM, Dheer S, Urbano C, Hartzell RW, Ronchetti-Blume M.
    J Biol Chem; 1988 Feb 25; 263(6):2917-24. PubMed ID: 3125172
    [Abstract] [Full Text] [Related]

  • 7. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
    de Vries C, Veerman H, Koornneef E, Pannekoek H.
    J Biol Chem; 1990 Aug 15; 265(23):13547-52. PubMed ID: 2143185
    [Abstract] [Full Text] [Related]

  • 8. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
    Bakker AH, Rehberg EF, Marotti KR, Verheijen JH.
    Protein Eng; 1995 Mar 15; 8(3):293-300. PubMed ID: 7479691
    [Abstract] [Full Text] [Related]

  • 9. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C, Veerman H, Blasi F, Pannekoek H.
    Biochemistry; 1988 Apr 05; 27(7):2565-72. PubMed ID: 3132969
    [Abstract] [Full Text] [Related]

  • 10. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
    Soeda S, Kakiki M, Shimeno H, Nagamatsu A.
    Biochim Biophys Acta; 1987 Dec 18; 916(3):279-87. PubMed ID: 3120775
    [Abstract] [Full Text] [Related]

  • 11. Effects of monoclonal antibodies on tissue-type plasminogen activator (t-PA) binding to lysine, fibrin and heparin and on fibrin-mediated enhancement of one-chain t-PA amidolytic activity.
    Fischer B, Zacharias U, Will H.
    Biol Chem Hoppe Seyler; 1991 Apr 18; 372(4):263-71. PubMed ID: 1905550
    [Abstract] [Full Text] [Related]

  • 12. Replacement of finger and growth factor domains of tissue plasminogen activator with plasminogen kringle 1. Biochemical and pharmacological characterization of a novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.
    Langer-Safer PR, Ahern TJ, Angus LB, Barone KM, Brenner MJ, Horgan PG, Morris GE, Stoudemire JB, Timony GA, Larsen GR.
    J Biol Chem; 1991 Feb 25; 266(6):3715-23. PubMed ID: 1847387
    [Abstract] [Full Text] [Related]

  • 13. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
    Wilhelm OG, Jaskunas SR, Vlahos CJ, Bang NU.
    J Biol Chem; 1990 Aug 25; 265(24):14606-11. PubMed ID: 2117612
    [Abstract] [Full Text] [Related]

  • 14. Localization of the binding site of tissue-type plasminogen activator to fibrin.
    Ichinose A, Takio K, Fujikawa K.
    J Clin Invest; 1986 Jul 25; 78(1):163-9. PubMed ID: 3088041
    [Abstract] [Full Text] [Related]

  • 15. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
    de Munk GA, Caspers MP, Chang GT, Pouwels PH, Enger-Valk BE, Verheijen JH.
    Biochemistry; 1989 Sep 05; 28(18):7318-25. PubMed ID: 2510823
    [Abstract] [Full Text] [Related]

  • 16. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
    Fischer B.
    Biomed Biochim Acta; 1991 Sep 05; 50(1):47-54. PubMed ID: 1830477
    [Abstract] [Full Text] [Related]

  • 17. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI, Leslie B, Ginsberg J.
    J Clin Invest; 1991 Mar 05; 87(3):1082-90. PubMed ID: 1900308
    [Abstract] [Full Text] [Related]

  • 18. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P, Boyer-Neumann C, Haverkate F, Grimbergen J, Larrieu MJ, Anglés-Cano E.
    Blood Coagul Fibrinolysis; 1993 Oct 05; 4(5):679-87. PubMed ID: 8292717
    [Abstract] [Full Text] [Related]

  • 19. Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties.
    Kalyan NK, Lee SG, Wilhelm J, Fu KP, Hum WT, Rappaport R, Hartzell RW, Urbano C, Hung PP.
    J Biol Chem; 1988 Mar 15; 263(8):3971-8. PubMed ID: 3126183
    [Abstract] [Full Text] [Related]

  • 20. Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.
    Fleury V, Loyau S, Lijnen HR, Nieuwenhuizen W, Anglés-Cano E.
    Eur J Biochem; 1993 Sep 01; 216(2):549-56. PubMed ID: 8375393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.